Dyfyniad APA

Wang, D., Wang, M., Jiang, N., Zhang, Y., Bian, X., Wang, X., . . . Cheng, H. (2016). Effective use of PI3K inhibitor BKM120 and PARP inhibitor Olaparib to treat PIK3CA mutant ovarian cancer. Oncotarget.

Dyfyniad Arddull Chicago

Wang, Dong, et al. "Effective Use of PI3K Inhibitor BKM120 and PARP Inhibitor Olaparib to Treat PIK3CA Mutant Ovarian Cancer." Oncotarget 2016.

Dyfyniad MLA

Wang, Dong, et al. "Effective Use of PI3K Inhibitor BKM120 and PARP Inhibitor Olaparib to Treat PIK3CA Mutant Ovarian Cancer." Oncotarget 2016.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.